Short Name |
RN |
Rα |
Rβ |
R2 |
R3 |
R4 |
R5 |
Full Name |
Biologic activity |
meta-Tyramine | | | | | OH | | | 3-hydroxyphenethylamine | Trace amine |
para-Tyramine | | | | | | OH | | 4-hydroxyphenethylamine | Trace amine |
Dopamine | | | | | OH | OH | | 3,4-dihydroxyphenethylamine | Catecholamine neurotransmitter |
Epinephrine (Adrenaline) | CH3 | | OH | | OH | OH | | β,3,4-trihydroxy-N-methylphenethylamine | Catecholamine neurotransmitter/Fight or Flight hormone |
Norepinephrine (Noradrenaline) | | | OH | | OH | OH | | β,3,4-trihydroxyphenethylamine | Catecholamine neurotransmitter/Fight or Flight hormone |
meta-Octopamine | | | OH | | OH | | | β,3-dihydroxyphenethylamine | Trace amine |
para-Octopamine | | | OH | | | OH | | β,4-dihydroxyphenethylamine | Trace aminergic α-adrenoceptor agonist |
Phenylephrine | CH3 | | OH | | OH | | | β,3-dihydroxy-N-methylphenethylamine | α-adrenergic agonist; decongestant |
6-Hydroxydopamine | | | | OH | | OH | OH | 2,4,5-trihydroxyphenethylamine | neurotoxic agent for the dopamine and norepinephrine receptors |
Salbutamol | C(CH3)3 | | OH | | | OH | CH2OH | β,4-dihydroxy-3-hydroxymethyl-N-tert-butylphenethylamine | Short-action β2-adrenergic agonist |
β-Methylphenethylamine | | | CH3 | | | | | β-methylphenethylamine | Stimulant |
Amphetamine | | CH3 | | | | | | α-methylphenethylamine | Monoamine releasing agent; Stimulant |
N-Methylphenethylamine | CH3 | | | | | | | N-methylphenethylamine | Trace amine; Endogenous amphetamine isomer |
Methamphetamine | CH3 | CH3 | | | | | | N-methylamphetamine; N,α-dimethylphenethylamine | Monoamine releasing agent; Stimulant; dopaminergic neurotoxin |
Phentermine | | 2CH3 | | | | | | α-methylamphetamine; α,α-dimethylphenethylamine | Stimulant, anorectic |
Ortetamine | | CH3 | | CH3 | | | | 2-methylamphetamine; 2,α-dimethylphenethylamine | Stimulant, anorectic |
Methylphenidate | -CH2-CH2-CH2-CH2- | C(OCH3)=O | | | | | N,α-butylene-β-methoxycarbonylphenethylamine | NDRI; Stimulant |
Ephedrine / Pseudoephedrine | CH3 | CH3 | OH | | | | | N-methyl-β-hydroxyamphetamine | Releasing agent; stimulant; decongestant |
Cathine | | CH3 | OH | | | | | d-β-hydroxyamphetamine | Somewhat selective norepinephrine releasing agent |
Cathinone | | CH3 | =O | | | | | β-ketoamphetamine | Selective norepinephrine and dopamine releasing agent |
Methcathinone | CH3 | CH3 | =O | | | | | N-methylcathinone | Selective norepinephrine and dopamine releasing agent |
Mephedrone | CH3 | CH3 | =O | | | CH3 | | 4-methylmethcathinone | Stimulant, unknown pharmacodynamics actions |
Ethcathinone | CH2CH3 | CH3 | =O | | | | | N-ethylcathinone | Stimulant and Norepinephrine releasing agent |
Bupropion | C(CH3)3 | CH3 | =O | | Cl | | | 3-chloro-N-tert-butyl-β-ketoamphetamine | NDRI |
Selegiline | CH2)CHCH | | | | [] | | | | |
Norfenfluramine | | CH3 | | | CF3 | | | 3-trifluoromethyl-amphetamine | SSRA |
Fenfluramine | CH2CH3 | CH3 | | | CF3 | | | 3-trifluoromethyl-N-ethylamphetamine | SSRA |
5-APB | | CH3 | | | -CH=CH-O- | | 5-(2-aminopropyl)benzofuran | stimulant, entactogen |
6-APB | | CH3 | | | -O-CH=CH- | | 6-(2-aminopropyl)benzofuran | stimulant, entactogen |
MDA | | CH3 | | | -O-CH2-O- | | 3,4-methylenedioxy-amphetamine | Stimulant, psychedelic, entactogen |
MDEA | CH2CH3 | CH3 | | | -O-CH2-O- | | 3,4-methylenedioxy-N-ethylamphetamine | psychedelic, entactogen and releasing agent |
MDMA | CH3 | CH3 | | | -O-CH2-O- | | 3,4-methylenedioxy-N-methylamphetamine | psychedelic, entactogen and releasing agent |
MDMC | CH3 | CH3 | =O | | -O-CH2-O- | | 3,4-methylenedioxymethcathinone | psychedelic, entactogen and releasing agent |
Mescaline | | | | | OCH3 | OCH3 | OCH3 | 3,4,5-trimethoxyphenethylamine | Serotonergic Psychedelic |
Proscaline | | | | | OCH3 | OCH2CH2CH3 | OCH3 | 2-(3,5-dimethoxy-4-propoxyphenyl)ethanamine | Stimulant, entactogen and euphoriant |
Metaescaline | | | | | OCH2CH3 | OCH3 | OCH3 | 2-(3-ethoxy-4,5-dimethoxyphenyl)ethanamine | Serotonergic Psychedelic, stimulant, entactogen and euphoriant |
Allylescaline | | | | | OCH3 | OCH2CH1CH2 | OCH3 | 4-Allyloxy-3,5-dimethyloxyphenylethylamine | Stimulant, entactogen and euphoriant |
Asymbescaline | | | | | OCH2CH3 | OCH2CH3 | OCH3 | 3,4-Diethoxy-5-methoxyphenethylamine | Psychedelic and euphoriant |
DOM | | CH3 | | OCH3 | | CH3 | OCH3 | 2,5-dimethoxy-4-methylamphetamine | psychedelic |
DOB | | CH3 | | OCH3 | | Br | OCH3 | 2,5-dimethoxy-4-bromoamphetamine | Psychedelic |
DOI | | CH3 | | OCH3 | | I | OCH3 | 2,5-dimethoxy-4-iodoamphetamine | Psychedelic |
DON | | CH3 | | OCH3 | | NO2 | OCH3 | 2,5-dimethoxy-4-nitroamphetamine | Stimulant |
DOC | | CH3 | | OCH3 | | Cl | OCH3 | 2,5-dimethoxy-4-chloroamphetamine | Psychedelic |
2C-B | | | | OCH3 | | Br | OCH3 | 2,5-dimethoxy-4-bromophenethylamine | Psychedelic, stimulant, entactogen and euphoriant |
βk-2C-B | | | =O | OCH3 | | Br | OCH3 | 2,5-dimethoxy-4-bromo-β-ketophenethylamine | Psychedelic, stimulant, entactogen and euphoriant |
2C-C | | | | OCH3 | | Cl | OCH3 | 2,5-dimethoxy-4-chlorophenethylamine | Psychedelic |
2C-I | | | | OCH3 | | I | OCH3 | 2,5-dimethoxy-4-iodophenethylamine | Psychedelic, stimulant |
2C-D | | | | OCH3 | | CH3 | OCH3 | 2,5-dimethoxy-4-methylphenethylamine | Psychedelic, stimulant |
2C-E | | | | OCH3 | | CH2-CH3 | OCH3 | 2,5-dimethoxy-4-ethylphenethylamine | Psychedelic |
2C-P | | | | OCH3 | | CH2-CH3-CH3 | OCH3 | 2,5-dimethoxy-4-propylphenethylamine | Entactogen, euphoriant and Psychedelic |
2C-F | | | | OCH3 | | F | OCH3 | 2,5-dimethoxy-4-fluorophenethylamine | None |
2C-N | | | | OCH3 | | NO2 | OCH3 | 2,5-dimethoxy-4-nitrophenethylamine | euphoriant |
2C-T-2 | | | | OCH3 | | S-CH2CH3 | OCH3 | 2,5-dimethoxy-4-ethylthio-phenethylamine | Psychedelic |
2C-T-4 | | | | OCH3 | | S-CH(CH3)2 | OCH3 | 2,5-dimethoxy-4-isopropylthio-phenethylamine | Psychedelic |
2C-T-7 | | | | OCH3 | | S-CH2CH2CH3 | OCH3 | 2,5-dimethoxy-4-propylthio-phenethylamine | Psychedelic |
2C-T-8 | | | | OCH3 | | S-CH2-C3H5 | OCH3 | 2,5-dimethoxy-4-cyclopropylmethylthio-phenethylamine | Psychedelic |
2C-T-19 | | | | OCH3 | | S-C(CH3)3 | OCH3 | 2,5-dimethoxy-4-tert-butylthio-phenethylamine | Psychedelic |
2C-T-21 | | | | OCH3 | | S-CH2-CH2-F | OCH3 | 2,5-dimethoxy-4-(2-fluoroethylthio)-phenethylamine | Psychedelic and euphoriant |
25B-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | Br | OCH3 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
25C-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | Cl | OCH3 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
25I-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | I | OCH3 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
25D-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | CH2 | OCH3 | 2-(4-methyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
25E-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | CH2-CH3 | OCH3 | 2-(4-ethyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
25P-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | CH2-CH3-CH3 | OCH3 | 2-(4-propyl-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
25F-NBOMe | CH2-C6H4-OCH3 | | | OCH3 | | F | OCH3 | 2-(4-fluoro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | Psychedelic |
Mescaline-NBOMe | CH2-C6H4-OCH3 | | | | OCH3 | OCH3 | OCH3 | N-(2-Methoxybenzyl)-2-(3,4,5-trimethoxyphenyl)ethanamine | Psychedelic |
25I-NBOH | CH2–C6H4–OH | | | OCH3 | | I | OCH3 | N-(2-hydroxybenzyl)-2,5-dimethoxy-4-iodo-phenethylamine | Psychedelic |
25C-NBOH | CH2–C6H4–OH | | | OCH3 | | Cl | OCH3 | N-(2-hydroxybenzyl)-2,5-dimethoxy-4-chloro-phenethylamine | Psychedelic |
25B-NBOH | CH2–C6H4–OH | | | OCH3 | | Br | OCH3 | N-(2-hydroxybenzyl)-2,5-dimethoxy-4-bromo-phenethylamine | Psychedelic |
25I-NBF | CH2–C6H4–F | | | OCH3 | | I | OCH3 | N-(2-fluorobenzyl)-2,5-dimethoxy-4-iodo-phenethylamine | Psychedelic |
Amfepramone (diethylpropion) | C2H5, C2H5[note 1] | CH3 | =O | | | | | N-diethyl-β-ketoamphetamine | Anorectic. |
Short Name |
RN |
Rα |
Rβ |
R2 |
R3 |
R4 |
R5 |
Full Name |
Biologic activity |